semaglutide california ban update Pushback against bill to limit access to GLP-1 | KTVU States Are Walking Back Medicaid

The ad made no mention of risks or side effects

Accurate statements use qualifiers: most patients, approximately X% of users, in clinical trials, Y% experienced. Examine financial motivations

Clinicians should conduct a thorough baseline assessment before initiating semaglutide in MS patients, including: Evaluation of current MS disease activity and disability status Assessment of gastrointestinal function and neurogenic bowel symptoms Review of concurrent medications, particularly MS treatments Screening for diabetic retinopathy if diabetes is present (semaglutide may increase risk of diabetic retinopathy complications) [9] [23] Renal function assessment Thyroid examination and history of thyroid disorders Patients should be counseled about the importance of maintaining adequate hydration and reporting any worsening of pre-existing MS symptoms

Whether choosing a GLP-1 pill vs injection, the decision should account for individual preferences, lifestyle, and insurance coverage